Jan 17, 2017

Malaria Drug Successfully Treats 26 Year Old Brain Cancer Patient

Posted by in categories: biotech/medical, neuroscience

Summary: Researchers report an anti malaria drug has helped improve length and quality of life for a 26 year old brain cancer patient.

Source: University of Colorado.

After her brain cancer became resistant to chemotherapy and then to targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a few months to live. Now a paper published January 17 in the journal eLife describes a new drug combination that has stabilized Rosendahl’s disease and increased both the quantity and quality of her life: Adding the anti-malaria drug chloroquine to her treatment stopped an essential process that Rosendahl’s cancer cells had been using to resist therapy, re-sensitizing her cancer to the targeted treatment that had previously stopped working. Along with Rosendahl, two other brain cancer patients were treated with the combination and both showed similar, dramatic improvement.

Read more

Comments are closed.